Thimerosal and Autism Risk Investigation
To convene
an outside panel of experts in this area to try
and review the, the, uh, the findings so far that had been gleaned,
to
review the discussions that had taken place within CDC at
that point
By this time, the autism risk had been watered down to
1.69.
But Verstraeten had been finding a link between thimerosal and a whole array of
developmental disorders.
I'm not even sure if they knew it was being, uh, recorded, but it was, and a
transcript was, was, was made.
They took the extraordinary step of convening this external panel,
which doesn't
happen.
The transcript were quite adamant that, that this was a linear
relationship, that they had a problem here.
There were neurodevelopmental specialists, there were pediatricians, there were
biostatisticians, there was an epidemiologist, me.
Thomas Verstraeten is quoted as saying,
"Personally, I have three hypotheses.
My first hypothesis is that it's parental bias.
The children that are more likely to be vaccinated
are more likely to be picked up
and diagnosed.
Second hypothesis, I don't know. There's a bias that I've not yet
recognized,
and nobody has yet told me about it. Third hypothesis, it's true.
It's thimerosal."
Dr. Weil from American Academy of Pediatrics
said, "You can play with it all you
want. The results are real. They're statistically significant."
They're not unexpectable, expected.
Not unexpected. Other people like, uh, Dr.
Clements from World Health Organization said, "You know, we could have predicted
this outcome before the d- we did the study,
and now we're left hanging, and we
should-"
We should have never done the study.
"We should have never done this study."
Now, other scientists were worried, not so much from a
medical point of view, but from a legal point of view.
They were worried about lawsuits.
They were worried about people suing the drug companies.
There was enough, enough, um, um,
evidence there.
Toward the end of discussions, the participants
were asked to vote on a scale of
one to six how serious they felt these findings were.
Most of the people who did vote, voted one or two.
In other words, not very serious. Of course, they were members of the
public health establishment with a big vested interest
in the vaccine program.
One of those who voted a one was the chair of the panel himself.
I remember the chair of the panel's grandson being born, uh,
or the announcement
happening literally as we were in the middle of discussions.
Stood up and said that earlier that morning,
he had been called out into the
hall
because his first male grandson had just been born,
and there was no way that they were gonna vaccinate
that baby with thimerosal.
Sir, would you all raise your right hand, please?
Do you solemnly swear to tell the whole truth and nothing but the truth, so help
you God?
I do.
Seated.
I was chairman of the Government Reform and Oversight Committee, and we did,
uh, about four years of investigation into
vaccines. I had scientists come from all over the
world
a- and doctors from all over the world to, uh, to, uh, discuss it before my
committee, and that's how we, uh, came to the conclusions we did.
If there's any question whatsoever about mercury in vaccine, if there's even a
question, why in the world are you continuing to immunize kids with
something that's questionable? You can't... I... Give me an answer.
I don't understand it.
To date, you know, there is no, we have no evidence,
convincing evidence of harm from the
thimerosal.
I, I know, doctor.
That's because in, in vaccines.
No, I'm gonna yield. Doctor, I understand. You said that, and I understand that.
Here was Congressman Burton from the Government Reform Committee, as the
chairperson, investigating the issue of thimerosal in
medicine,
and they didn't tell the committee anything.
Can you imagine what that was like?
One day, they're behind closed doors, "We found all these effects.
Oh my God, what are we gonna do about it?" Next day,
testify before Congress, "No
links, no data. We need to do studies in the future."
Everything's fine.
If he had told the truth and pulled out from Simpsonwood a draft of
that
study, just think of how many thousands, probably tens of thousands
of children would've been spared.
When we had our hearings,
uh, we had somebody from the FDA testifying,
and I, uh, said
that, "My grandson got seven shots with mercury
in them, uh, and became
autistic very s- very shortly." And he said, "Well,
the, there's no, no evidence that that caused it." And I said,
"Would you like for
me to give you the content that was in there of mercury, seven
shots full? Would you let me shoot that into your arm?" And he looked at
me like he was shot, and said, "Well, no."
And I said, "Well, why?
If it's all right for my grandson to get seven shots with mercury in it, why is it
not, not all right for you to take one shot
with the same amount of mercury that he
got?"
One month after the Simpsonwood conference,
Thomas Verstraeten sent an email to
voice his frustrations over the pressure he was under to reduce the relative
risks. "I do not wish to be the advocate of the
anti-vaccine lobby and sound like
being convinced that thimerosal is or was harmful, but at least I feel we should
use sound scientific argumentation and not let our standards be dictated by
our
desire to disprove an unpleasant theory."
That was basically the end of Verstraeten's tenure at CDC.
Once he said that, he was doomed.
Then a year later, the fourth generation was presented at
the Institute of Medicine committee meeting that was held in
2001. There were two IOM meetings on vaccines.
The Institute of Medicine, known as the IOM,
was paid by the CDC to perform
two separate reviews of the evidence in relation to vaccines and autism.
The first was the 2001 IOM, and by this time, Verstraeten's fourth
generation showed a relative risk for autism that had once again been lowered,
this
time to 1.52.
When Verstraeten
presented his data that morning at the IOM, he said,
"As of 8:00 this morning, I no longer work for the CDC.
I am now an employee of GlaxoSmithKline, and I'll be going
back to Belgium to work for their Brussels office." Well, Glaxo, of course, is a
vaccine maker, uses thimerosal, and is a defendant in a lot of
lawsuits.
The 2001 IOM concluded the link between autism and thimerosal is
biologically plausible.
They emphasized the need to perform biological and clinical science.
After the IOM '01 report that found biologic plausibility,
the trial lawyers
came out of the woodwork and were filing class actions in civil court
and were kind
of gearing up the whole litigation machinery to go after industry,
and Eli Lilly
came along with a rider, Tollman Security Act, that would have
given the vaccine companies permanent immunity from suit.
10 years ago, it was 1 in 10,000.
Now, it's 1 in 250, a 40-fold increase in 10
years, and we had the audacity to take the only
tool
that these parents had out of their hands
End of transcript · 1,225 words